Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib Modulation of Surgical Inflammatory Response
NCT00746720Phase 2Terminated
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- May 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoricoxib in postoperative pain, sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started May 2006; status: terminated.
02
Drugs
etoricoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00746720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746720.